comparison of glp-1 integrated weight management platforms Understanding Loss Medications: vs. Phentermine Market Overview: GLP-1 Agonists and

Standard practice includes: Baseline thyroid function tests (TSH and free T4) before initiating GLP-1 therapy Repeat testing at 812 weeks after starting treatment or after dose escalation Regular monitoring every 36 months during active weight loss Return to annual monitoring once weight is stable and thyroid function remains consistent Adjustments to levothyroxine dosing may be necessary as weight changes

To survive this "acid bath," the oral GLP-1 contains a specialized buffer that temporarily neutralizes the surrounding stomach acid, creating a protective window just long enough for the pill to pass directly through the stomach lining and into the bloodstream

While a direct comparison is hard (due to differences in study designs), it seems that tirzepatide is a better overall drug for weight loss (and also shows greater reduction in A1C)

How do clinical trials fit into this